Gastrointestinal Cancers (Issue 5) | Special Reports

Proteomic Study in CRC of Paired Tumor Versus Nontumor Tissue May Identify New Biomarkers

July 16, 2015

Clinical Articles

One gene can encode more than one protein; however, proteins are dynamic (binding to membranes, other proteins, synthesis, degradation), undergo co- and post-translational modification, and exist in a wide range of concentrations in the body.

Managing the Elderly Patient With Unresectable HCC: Q and A With Pierre M. Gholam, MD, AGAF

July 15, 2015

Clinical Articles

In a 2015, retrospective single-center study, patients with advanced HCC received systemic therapy with sorafenib combined with transarterial chemoembolization (TACE), and outcomes were compared between elderly (>70 years) and nonelderly (

Prevention and Screening of CRC

July 10, 2015

Clinical Articles

Nadir Arber, MD, MSc, MHA, director of the Integrated Cancer Prevention Center (ICPC), Tel Aviv Sourasky Medical Center, discusses prevention and screening of colorectal cancer (CRC).

Survival Differences in KRAS/BRAF Mutations in mCRC

July 10, 2015

Clinical Articles

Halfdan Sorbye, MD, professor, Department of Oncology and Medical Physics, Haukeland University Hospital, University of Bergen, discusses the survival differences in KRAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC).

New Agents Show Potency for Patients with HCC

July 09, 2015

Clinical Articles

New agents that focus on the duplication of HCV are poised to majorly impact the prevention and recurrence of HCC, as well as show the ability to reverse liver fibrosis and cirrhosis in the treatment of patients with end-stage HCC.

Success of Regorafenib Confirmed in Patients With mCRC

July 09, 2015

Clinical Articles

Results of a large expanded access program, presented at the 2015 World Congress on GI Cancer, confirmed the efficiency and safety of regorafenib (Stivarga) in previously treated patients with mCRC.